The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.

Abstract:

:Rheumatoid arthritis (RA) and osteoarthritis are chronic diseases that result in cartilage degradation and loss of joint function. Currently available drugs are predominantly directed towards the control of pain and/or the inflammation associated with joint synovitis but they do little to reduce joint destruction. In the future, it will be important to have drugs that prevent the structural damage caused by bone and cartilage breakdown. In this review, we will outline the structure and function of cartilage and the key features of matrix metalloproteinases (MMPs), enzymes involved in joint destruction. We will present evidence for the role of MMPs in RA and osteoarthritis, and describe the potential of synthetic inhibitors to control MMP activity and so prevent joint destruction. MMPs are able to cleave all components of the cartilage matrix. Regulation of MMPs is aberrant in osteoarthritis and RA, and MMPs have been implicated in the collagen breakdown that contributes to joint destruction in these diseases. Synthetic MMP inhibitors have been developed. In animal models of osteoarthritis and/or RA, these agents have shown chondroprotective effects. However, results from clinical trials in RA have been equivocal, with some studies being terminated because of lack of efficacy or safety concerns. Nevertheless, this approach remains promising. Increased understanding of the structure, regulation and function of individual MMPs may lead to more effective strategies, and approaches aimed at multiple steps of the pathogenesis of arthritis may be needed to break the chronic cycle of joint destruction.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Elliott S,Cawston T

doi

10.2165/00002512-200118020-00002

subject

Has Abstract

pub_date

2001-01-01 00:00:00

pages

87-99

issue

2

eissn

1170-229X

issn

1179-1969

journal_volume

18

pub_type

杂志文章,评审
  • Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care.

    abstract:BACKGROUND:Inappropriate polypharmacy may negatively impact the quality of life of residents in aged care facilities, but it remains unclear which medications may influence this reduced quality of life. OBJECTIVE:The objective of this study was to examine whether the Drug Burden Index and potentially inappropriate med...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-017-0513-3

    authors: Harrison SL,Kouladjian O'Donnell L,Bradley CE,Milte R,Dyer SM,Gnanamanickam ES,Liu E,Hilmer SN,Crotty M

    更新日期:2018-01-01 00:00:00

  • Factors influencing the implementation of quality use of medicines in residential aged care.

    abstract:BACKGROUND:In response to concerns about, and issues pertaining to, medication use practices in residential aged-care facilities (RACFs), the Australian Pharmaceutical Advisory Council (APAC) established a working party on quality use of medicines (QUM) in nursing homes and hostels. The APAC is a representative ministe...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421120-00005

    authors: Cheek J,Gilbert A,Ballantyne A,Penhall R

    更新日期:2004-01-01 00:00:00

  • Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

    abstract::Osteoarthritis (OA) is a major cause of pain and physical disability in adults, and an increasingly common disease given its associations with aging and a growing obese/overweight population. Paracetamol is widely recommended for analgesia at an early stage in the management of OA, and, although frequently prescribed,...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-019-00658-9

    authors: Conaghan PG,Arden N,Avouac B,Migliore A,Rizzoli R

    更新日期:2019-04-01 00:00:00

  • Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.

    abstract:BACKGROUND:Evidence regarding differences in outcomes between angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) among older nursing home (NH) residents after acute myocardial infarction (AMI) is limited. OBJECTIVES:The purpose of our study was to estimate the post-AMI effects...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00791-w

    authors: Zullo AR,Riester MR,Erqou S,Wu WC,Rudolph JL,Steinman MA

    更新日期:2020-10-01 00:00:00

  • Association Between Potentially Inappropriate Medications and Hospital Encounters Among Older Adults: A Meta-Analysis.

    abstract:BACKGROUND:Potentially inappropriate medications (PIMs) are defined by the American Geriatric Society as medications that should be avoided in the elderly in general, or in specific situations. However, PIM use remains high among aging populations and may result in increased utilization of healthcare resources. OBJECT...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析

    doi:10.1007/s40266-020-00770-1

    authors: Weeda ER,AlDoughaim M,Criddle S

    更新日期:2020-07-01 00:00:00

  • Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

    abstract::Alzheimer's disease is the most common major neurocognitive disorder with substantial social and economic impacts. This article is an update on current pharmacotherapy, advancements in biomarker use, and drugs in the pipeline for this disease. To date, no new drug has qualified to be added to the current therapeutic a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0499-x

    authors: Khoury R,Patel K,Gold J,Hinds S,Grossberg GT

    更新日期:2017-11-01 00:00:00

  • Stroke prevention in atrial fibrillation: putting the guidelines into practice.

    abstract::Atrial fibrillation confers a 5-fold increase in risk of stroke. A number of drugs aimed at reducing this risk have been tested in randomized controlled trials. These include antiplatelet agents (singly and in combination); anticoagulants, including vitamin K antagonists and direct thrombin inhibitors; and anticoagula...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11538620-000000000-00000

    authors: Mant J,Edwards D

    更新日期:2010-11-01 00:00:00

  • Antipsychotics in older patients. A safety perspective.

    abstract::Age is a major source of variation in drug response. Social, medical and physiological heterogeneity intertwines to complicate geriatric pharmacotherapy. Inappropriate and excessive use of medication may be the most significant treatable health problem in the elderly. Older people are especially sensitive to antipsych...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199506040-00006

    authors: Pollock BG,Mulsant BH

    更新日期:1995-04-01 00:00:00

  • Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.

    abstract:BACKGROUND:Patients hospitalised with severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2; coronavirus 2019 disease (COVID-19)] infection are frequently older with co-morbidities and receiving polypharmacy, all of which are known risk factors for drug-drug interactions (DDIs). The pharmacological burden may be ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-020-00812-8

    authors: Cattaneo D,Pasina L,Maggioni AP,Giacomelli A,Oreni L,Covizzi A,Bradanini L,Schiuma M,Antinori S,Ridolfo A,Gervasoni C

    更新日期:2020-12-01 00:00:00

  • Medication-related admissions in older people: a cross-sectional, observational study.

    abstract:BACKGROUND:Medication-related admissions are an important cause of hospital admissions in older people. The scope for prevention is less clear. OBJECTIVES:To characterize medication-related hospital admissions in older people and assess their preventability. METHODS:This was a cross-sectional, observational study con...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11316750-000000000-00000

    authors: Rogers S,Wilson D,Wan S,Griffin M,Rai G,Farrell J

    更新日期:2009-01-01 00:00:00

  • Adverse effects of clozapine in older patients: epidemiology, prevention and management.

    abstract::Research into the use of clozapine in older people is somewhat scarce. Clozapine is associated with serious adverse effects such as agranulocytosis, seizures, myocarditis and metabolic syndrome. Other common undesirable effects such as sedation, constipation (which can be fatal), urinary incontinence and hypersalivati...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-013-0144-2

    authors: Bishara D,Taylor D

    更新日期:2014-01-01 00:00:00

  • Psychotropic drug-induced falls in older people: a review of interventions aimed at reducing the problem.

    abstract::Falls are a common health problem for older people, and psychotropic medications have been identified as an important independent fall risk factor. The objective of this paper was to review the literature relating to the effect of psychotropic medications on falls in older people, with a particular focus on evidence s...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11598420-000000000-00000

    authors: Hill KD,Wee R

    更新日期:2012-01-01 00:00:00

  • Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

    abstract::Nadroparin (nadroparin calcium) is a low molecular weight heparin with a mean molecular weight of 4.5 kD. Compared with unfractionated heparin (UFH), nadroparin has a greater ratio of anti-factor Xa to anti-factor Ha activity, greater bioavailability and a longer duration of action, allowing it to be administered by s...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710040-00006

    authors: Davis R,Faulds D

    更新日期:1997-04-01 00:00:00

  • Rational approach to the antibiotic treatment of pneumonia in the elderly.

    abstract::The incidence of pneumonia is highest among the aged compared with other adult populations, and causes significant morbidity and mortality among this group. Most episodes of pneumonia are caused by aspiration of oropharyngeal flora into the lungs and failure of lung defence mechanisms to eliminate the aspirated bacter...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199404010-00003

    authors: Mylotte JM,Ksiazek S,Bentley DW

    更新日期:1994-01-01 00:00:00

  • Repeat Adverse Drug Reaction-Related Hospital Admissions in Elderly Australians: A Retrospective Study at the Royal Hobart Hospital.

    abstract:BACKGROUND:Adverse drug reactions are a major cause of hospital admissions in older individuals, with the majority potentially preventable. Despite the apparent magnitude of this problem, little is known about rates of repeat admission to hospital as a result of adverse drug reactions. OBJECTIVES:The objectives of thi...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-017-0490-6

    authors: Parameswaran Nair N,Chalmers L,Bereznicki BJ,Curtain CM,Bereznicki LR

    更新日期:2017-10-01 00:00:00

  • Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

    abstract::Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may expla...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320130-00001

    authors: Legrain S,Girard L

    更新日期:2003-01-01 00:00:00

  • Spasticity after stroke. Epidemiology and optimal treatment.

    abstract::Spasticity following stroke reflects a spectrum of clinical problems including increased muscle tone, abnormal limb posture, excessive contraction of antagonist muscles and hyperactive cutaneous and tendon reflexes. The prevalence of stroke-related disability in stroke survivors is high, and spasticity may be a signif...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199609050-00004

    authors: O'Brien CF,Seeberger LC,Smith DB

    更新日期:1996-11-01 00:00:00

  • Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

    abstract::Cyproterone (cyproterone acetate) is a steroidal antiandrogenic agent that inhibits the action of adrenal and testicular androgens on prostatic cells. Additionally, its progestogenic activity causes a centrally mediated reduction in testicular secretion of androgens. Studies have demonstrated the effectiveness of cypr...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405010-00006

    authors: Barradell LB,Faulds D

    更新日期:1994-07-01 00:00:00

  • Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

    abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711040-00006

    authors: Foster RH,Balfour JA

    更新日期:1997-10-01 00:00:00

  • Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study.

    abstract:BACKGROUND:Increased life expectancy is associated with an increased prevalence of chronic diseases and drug consumption. Changes often occur in the medication regimen after hospitalization. The extent and nature of these changes and the adherence of elderly patients have not yet been fully investigated. OBJECTIVE:To ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825100-00005

    authors: Mansur N,Weiss A,Hoffman A,Gruenewald T,Beloosesky Y

    更新日期:2008-01-01 00:00:00

  • Improving elder care by integrating geriatric expertise into medicare: a proposal.

    abstract::The Medicare programme already funds a large proportion of the medical care for older Americans. However, geriatricians are an underutilized resource for improving the quality of care delivered with Medicare funding, particularly to the most complex patients. Recent legislative changes will increase the involvement of...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522050-00002

    authors: Nusbaum NJ

    更新日期:2005-01-01 00:00:00

  • Managing alcohol withdrawal in the elderly.

    abstract::The alcohol withdrawal syndrome is common in elderly individuals who are alcohol dependent and who decrease or stop their alcohol intake. While there have been few clinical studies to directly support or refute the hypothesis that withdrawal symptom severity, delirium and seizures increase with advancing age, several ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199914060-00002

    authors: Kraemer KL,Conigliaro J,Saitz R

    更新日期:1999-06-01 00:00:00

  • Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

    abstract::Intracavernous alprostadil (synthetic prostaglandin E1) is a vasodilating agent which acts by relaxing the smooth muscles of the corpus cavernosum and by increasing the diameter of cavernous arteries; this leads to erection. Following intracavernous administration, alprostadil is either locally metabolised or rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608010-00009

    authors: Lea AP,Bryson HM,Balfour JA

    更新日期:1996-01-01 00:00:00

  • Molecular rationale for the pharmacological treatment of Alzheimer's disease.

    abstract::Cerebral deposition of amyloid plaques containing amyloid beta-peptide (Abeta) has traditionally been considered the central feature of Alzheimer's disease (AD). Abeta is derived from amyloid precursor protein (APP), which is cleaved by several different proteases: alpha-, beta- and gamma-secretase. In the past decade...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522001-00003

    authors: Zimmermann M,Gardoni F,Di Luca M

    更新日期:2005-01-01 00:00:00

  • Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

    abstract::Systemic fungal infections are an increasing problem in older adults. For several of the endemic mycoses, this increase is the result of increased travel and leisure activities in areas endemic for these fungi. Immunosuppressive agents, care in an intensive care unit, and invasive devices all contribute to infection w...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118050-00002

    authors: Kauffman CA,Hedderwick SA

    更新日期:2001-01-01 00:00:00

  • Feasibility of chemoradiotherapy for oesophageal cancer in elderly patients aged >or=75 years: a prospective, single-arm phase II study.

    abstract:BACKGROUND:The number of elderly patients with oesophageal cancer is expected to increase with the aging of the population and the rapidly increasing incidence of adenocarcinoma. Surgical resection is standard treatment for patients with localized disease considered fit for operation. However, elderly patients with oes...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200926030-00006

    authors: Servagi-Vernat S,Bosset M,Crehange G,Buffet-Miny J,Puyraveau M,Maingon P,Mercier M,Bosset JF

    更新日期:2009-01-01 00:00:00

  • Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.

    abstract:BACKGROUND:Improvement in renal function and decreases in serum uric acid (SUA) have been reported following prolonged high-intensity statin (HMG-CoA reductase inhibitor) therapy. This post hoc analysis of the SAGE trial examined the effect of intensive versus less intensive statin therapy on renal function, safety, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-015-0328-z

    authors: Deedwania PC,Stone PH,Fayyad RS,Laskey RE,Wilson DJ

    更新日期:2015-12-01 00:00:00

  • Management of lipid disorders in the elderly.

    abstract::Cardiovascular disease has been inseparable from aging in developed societies and, as a result, it is the commonest cause of mortality in elderly populations. Atherosclerosis is associated with the progressive vascular accumulation of cholesterol-laden lipoproteins, and is linearly associated with the plasma level of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710060-00005

    authors: Playford DA,Watts GF

    更新日期:1997-06-01 00:00:00

  • Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.

    abstract:BACKGROUND:Because of co-morbidity, older persons are often exposed to use of an excessive number of drugs, which per se implies also use of inappropriate drugs or of potentially interacting drugs ('suboptimal prescribing'). Time trends of suboptimal prescribing in older, community dwellers have been poorly investigate...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11319390-000000000-00000

    authors: Lapi F,Pozzi C,Mazzaglia G,Ungar A,Fumagalli S,Marchionni N,Geppetti P,Mugelli A,Di Bari M

    更新日期:2009-01-01 00:00:00

  • Aspirin and heparin in acute ischaemic stroke in older patients.

    abstract::Over four-fifths of all strokes are due to thrombotic or embolic occlusion of cerebral arteries. There is a strong rationale for considering antithrombotic therapy for the treatment of patients with acute ischaemic stroke. Antiplatelet therapy with 150 to 300 mg of aspirin (acetylsalicylic acid) started within the fir...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199915010-00003

    authors: Gubitz GJ,Sandercock PA

    更新日期:1999-07-01 00:00:00